Squarepoint Ops LLC Soleno Therapeutics Inc Transaction History

Squarepoint Ops LLC

  • $62.8 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 17, 2021
SELL
$1.24 - $3.3 $46,451 - $123,621
-37,461 Closed
0 $0
Q4 2020

Feb 16, 2021
SELL
$1.61 - $2.23 $321,880 - $445,834
-199,926 Reduced 84.22%
37,461 $72,000
Q3 2020

Nov 16, 2020
SELL
$1.71 - $2.51 $86,948 - $127,625
-50,847 Reduced 17.64%
237,387 $596,000
Q2 2020

Aug 14, 2020
BUY
$1.77 - $4.23 $437,259 - $1.04 Million
247,039 Added 599.68%
288,234 $640,000
Q1 2020

May 15, 2020
BUY
$1.64 - $3.85 $67,559 - $158,600
41,195 New
41,195 $98,000

About SOLENO THERAPEUTICS INC

SLNO Quotes by TradingView
  • Ticker SLNO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 8,101,250
  • Market Cap $352M
  • Description
  • Soleno Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its lead candidate is Diazoxide Choline Controlled-Release, a once-daily oral tablet for the treatment of Prader-Willi Syndrome, which is being evaluated in an ongoing P...
More about SLNO
Track This Portfolio

Track Squarepoint Ops LLC Portfolio

Follow Squarepoint Ops LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

News

Stay updated on Squarepoint Ops LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email